Follow SiliCycle on Facebook Follow SiliCycle on Twitter Follow SiliCycle on LinkedIn Watch our videos on Youtube

Continuous Flow Synthesis of Telmisartan enabled by SiliaCat DPP-Pd

SiliaCat DPP-Pd promotes the key Suzuki coupling step in the synthesis of Telmisartan, an antihypertensive drug, under continuous flow conditions.

Telmisartan (Micardis) is an antihypertensive drug that recently lost patent protection in the United States. Hence, there is interest in the development of novel synthetic schemes for this molecule. The classical batch approach was modified to a flow process, thus telescoping three steps (N-alkylation, saponification, Suzuki coupling) without isolation of intermediates or solvent exchange. The key Suzuki coupling, which previously used PdCl2dppf under homogeneous, batch conditions, was enabled by SiliaCat DPP-Pd. The heterogenous catalyst was packed in a flow cartridge mounted on a ThalesNano X-Cube. This new strategy cleanly yielded Talmisartan in 81% yield (1 mg/min) over three steps in 97% purity after simple aqueous workup.

Flow chemistry, bioactive compounds, Suzuki coupling, Telmisartan

Publication A Flow-based Synthesis of Telmisartan
Authors Alex D. Martin, Ali R. Siamaki, Katherine Belecki, B. Frank Gupton
Organization Department of Chemistry and Department of Chemical and Life Science Engineering
Virginia Commonwealth University 601 W. Main St. Richmond Virginia 23284 United States
Source Journal of Flow Chemistry
Akadémiai Kiadó
2062-249X (Print)
2063-0212 (Online)
Flow Chemistry
Pages 1-1
Date 2015
Reaction scheme Continuous Flow Synthesis of Telmisartan enabled by SiliaCat DPP-Pd
Full publication